Takeda Pharmaceutical Co Ltd

SUSQUEHANNA INTERNATIONAL GROUP, LLP TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

28,675

Value ($000)

447

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	447	0.0%	28,675	12/31/2025
2025 Q2	8/14/2025	167	0.0%	10,810	6/30/2025
2025 Q1	5/14/2025	699	0.0%	47,029	3/31/2025
2024 Q4	2/14/2025	343	0.0%	25,911	12/31/2024
2024 Q3	11/14/2024	203	0.0%	14,292	9/30/2024
2024 Q1	5/7/2024	147	0.0%	10,569	3/31/2024
2023 Q4	2/14/2024	551	0.0%	38,638	12/31/2023
2023 Q3	11/14/2023	175	0.0%	11,315	9/30/2023
2023 Q1	5/16/2023	192	0.0%	11,668	3/31/2023
2022 Q4	2/14/2023	1,501	0.0%	96,219	12/31/2022
2022 Q3	11/14/2022	392	0.0%	30,225	9/30/2022
2022 Q2	8/15/2022	2,560	0.0%	182,342	6/30/2022
2022 Q1	5/16/2022	3,864	0.0%	269,820	3/31/2022
2021 Q4	2/14/2022	7,536	0.0%	552,865	12/31/2021
2021 Q3	11/15/2021	18,228	0.0%	1,112,808	9/30/2021
2021 Q2	8/11/2021	19,031	0.0%	1,130,758	6/30/2021
2021 Q1	5/17/2021	28,113	0.0%	1,539,585	3/31/2021
2020 Q4	2/16/2021	18,496	0.0%	1,016,287	12/31/2020
2020 Q3	11/16/2020	8,255	0.0%	462,737	9/30/2020
2020 Q2	8/14/2020	7,141	0.0%	398,287	6/30/2020
2020 Q1	5/15/2020	9,689	0.0%	638,254	3/31/2020
2019 Q4	2/14/2020	3,059	0.0%	155,028	12/31/2019